Intrathecal Drug Delivery System: A Pain Management Option for Refractory Cancer-Related Pain

被引：3
|
作者：
Wanderman, Robalee L. [1 ]
Hagedorn, Jonathan M. [1 ]
机构：
[1] Mayo Clin, Div Pain Med, Dept Anesthesiol & Perioperat Med, 200 First St SW, Rochester, MN 55905 USA
来源：
PAIN MEDICINE | 2021年 / 22卷 / 02期
关键词：
Cancer Pain; Intrathecal Drug Delivery System; Opioids; CONFERENCE PACC RECOMMENDATIONS; THERAPY;
D O I：
10.1093/pm/pnaa364
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Cancer-related pain is progressive and therefore requires a stepwise approach to management, such as the World Health Organization's Pain Ladder. This approach calls for increasingly strong pain medications in addition to interventional options for patients with medication-refractory pain or intolerable medication side effects. Here, we discuss a case involving cancer-related pain which ultimately required intrathecal drug delivery system placement for optimal pain management.
引用
收藏
页码：523 / 526
页数：4
相关论文
共 50 条
  • [21] Strategies for interventional therapies in cancer-related pain—a crossroad in cancer pain management
    Gilles Allano
    Brigitte George
    Christian Minello
    Alexis Burnod
    Caroline Maindet
    Antoine Lemaire
    Supportive Care in Cancer, 2019, 27 : 3133 - 3145
  • [22] Corticosteroids for the management of cancer-related pain in adults
    Haywood, Alison
    Good, Phillip
    Khan, Sohil
    Leupp, Aurelia
    Jenkins-Marsh, Sue
    Rickett, Kirsty
    Hardy, Janet R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [23] Breaking Barriers: Management of Cancer-Related Pain
    von Gunten, Charles
    JOURNAL OF CANCER EDUCATION, 2009, 24 (03) : 244 - 244
  • [24] Intrathecal drug delivery for chronic pain management-scope, limitations and future
    Czernicki, M.
    Sinovich, G.
    Mihaylov, I.
    Nejad, B.
    Kunnumpurath, S.
    Kodumudi, G.
    Vadivelu, N.
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2015, 29 (02) : 241 - 249
  • [25] The Rate of Infectious Complications After Intrathecal Drug Delivery System Implant for Cancer-Related Pain Is Low Despite Frequent Concurrent Anticancer Treatment or Leukopenia
    Sindt, Jill E.
    Larsen, Steven D.
    Dalley, Andrew P.
    Collier, Willem H.
    Brogan, Shane E.
    ANESTHESIA AND ANALGESIA, 2020, 131 (01) : 280 - 287
  • [26] Intrathecal drug delivery for chronic pain management-scope, limitations and future
    M. Czernicki
    G. Sinovich
    I. Mihaylov
    B. Nejad
    S. Kunnumpurath
    G. Kodumudi
    N. Vadivelu
    Journal of Clinical Monitoring and Computing, 2015, 29 : 241 - 249
  • [27] Drug management of cancer-related peripheral neuropathic pain: A systematic review of the literature
    Medioni, Jacques
    Pickering, Gisele
    Delorme, Claire
    Lansaman, Thibaud
    Lanteri-Minet, Michel
    Legras, Antoine
    Navez, Malou
    Prudhomme, Michel
    Serrie, Alain
    Viel, Eric
    Perrot, Serge
    BULLETIN DU CANCER, 2019, 106 (09) : 784 - 795
  • [28] Pharmacotherapy of cancer-related episodic pain
    Zeppetella, G
    Ribeiro, MDC
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (04) : 493 - 502
  • [29] Exceptional Cases of Spinal Cord Stimulation for the Treatment of Refractory Cancer-Related Pain
    Bulat, Evgeny
    Chakravarthy, Vikram
    Crowther, Jason
    Rakesh, Neal
    Barzilai, Ori
    Gulati, Amitabh
    NEUROMODULATION, 2023, 26 (05): : 1051 - 1058
  • [30] Successful Management of Corneal Neuropathic Pain with Intrathecal Targeted Drug Delivery
    Hayek, Salim M.
    Sweet, Jennifer A.
    Miller, Jonathan P.
    Sayegh, Rony R.
    PAIN MEDICINE, 2016, 17 (07) : 1302 - 1307
12345